Vivek Rugpulled
Vivek's company Axovant Gene Therapies owned a drug called Intepirdine which failed to pass Phase 2 clinical trials. His solution was to redo the trials, but this time they were conducted by his mother Geetha. Incredibly, the trials demonstrated significant improvements from the last ones, enough to move on to Phase 3. At this point, he took his company public for a $315 million IPO in 2015, the largest of any biotech company in history. When the drug moved onto phase 3 trials that were not conducted by his mother, they failed, and the company lost 75% of its value in a single day. Luckily for Vivek, however, he had already sold tens of millions of dollars in his shares of the company, and so the losses didn't hurt his wallet.
Why This Matters
- Deeply immoral. Making your fortune on a crypto rugpull is bad enough, but to set up your pump and dump on a fraudulent promise of curing Alzheimer's is evil. Only someone with no character could do such a thing.
- Just another Soulless Big Pharma puppet. America and Ohio don't need even more Big Pharma creatures who make their living profiting off people's misery to come and rule over us. In fact, Vivek is so shameless in exploiting people's poor health for profit that he named first Biotech Company "Roivant Sciences" because the first three letters, "ROI" stands for "Return on Investment."
- Parasitic Ruler. As a business owner he brought no value to the people of his society but made a personal fortune manipulating the system. A man like that would run Ohio into the ground if it meant lining his pockets.
